PTC Therapeutics
PTCT
PTCT
148 hedge funds and large institutions have $1.15B invested in PTC Therapeutics in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+23
Holders Change %
+18.4%
% of All Funds
3.4%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
42
Increased
40
Reduced
45
Closed
18
Calls
$24.3M
Puts
$27.1M
Net Calls
-$2.81M
Net Calls Change
+$36M
Top Buyers
| 1 |
SCM
Scopia Capital Management
New York
|
+$47.9M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$22.9M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$17.9M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$14.5M |
| 5 |
Morgan Stanley
New York
|
+$13M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$15.2M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$14.2M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$10.9M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$10.6M |
| 5 |
SIM
Spark Investment Management
New York
|
-$10.3M |
